Skip to main content
. Author manuscript; available in PMC: 2015 Feb 10.
Published in final edited form as: Chembiochem. 2014 Jan 29;15(3):435–442. doi: 10.1002/cbic.201300701

Scheme 1.

Scheme 1

Structures of compounds subjected to LasR antagonism dose-response analyses in this study. A) AHLs exhibiting ≥25% inhibition of LasR in the primary LasR antagonism screen in pump-active P. aeruginosa PAO-JP2. B) Non-AHL-based compounds chosen due to their activities in QS phenotypic screens in wild-type P. aeruginosa.